Annual Meeting News

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) will hold its 2025 Annual Meeting of Stockholders virtually on Thursday, November 13, 2025 beginning at 9:00 a.m. (ET). Those wishing to access the webcast can visit: www.virtualshareholdermeeting.com/EL2025. For further information on the meeting, The Estée Lauder Companies’ proxy statement materials and other information are available at www.elcompanies.com/investors. Following the annual meeting, a webcast of the meeting w...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting on November 7-10, 2025 in National Harbor, Maryland. The company will showcase how researchers can generate a combination of high-quality RNA and protein data via Vizgen’s bioinformatics technology. Vizgen combined results...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Montai will present data for the first time on its novel oral NRF2 agonist molecule, MTAI-1025, for ulcerative colitis (UC) during ACAAI in Orlando....

LAS VEGAS--(BUSINESS WIRE)--Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that it has filed its definitive proxy statement and WHITE proxy card with the U.S. Securities and Exchange Commission (“SEC”) in connection with its upcoming 2025 Annual Meeting of Shareholders (the “Annual Meeting”) to be held on December 12, 2025. Cannae is urging all shareholders to vote on the WHITE proxy card and to protect their investment by voting “FOR” ONLY Cannae’s four highly q...

PROVIDENCE, R.I.--(BUSINESS WIRE)--At the Greater Providence Chamber of Commerce (GPCC) Annual Meeting yesterday, Citizens Financial Group Chairman and CEO Bruce Van Saun shared an optimistic outlook for Rhode Island’s business climate, emphasizing the state’s readiness for growth and innovation. During a fireside chat moderated by GPCC Chair Rick Metters, Van Saun addressed more than 400 business leaders and community partners, outlining the unique opportunities ahead for Rhode Island and the...

PARIS--(BUSINESS WIRE)--Claranova informs its shareholders that its Combined General Meeting (Ordinary and Extraordinary) will be held on Wednesday, December 10, 2025....

CHICAGO--(BUSINESS WIRE)--Alight, Inc. (the “Company” or “Alight”) (NYSE: ALIT), a leading cloud-based human capital and technology-enabled services provider, announced that its Board of Directors has approved declassifying the Board and intends to ask stockholders to vote on a proposal to approve amendments to the Company’s Certificate of Incorporation to effectuate the phased declassification of the Board (the “Declassification Proposal”) at the 2026 annual meeting of stockholders (the “2026...

LYON, France--(BUSINESS WIRE)--Regulatory News: This replaces the announcement made at 8:58 AM CET on November 5th, 2025 due to corrections. Poxel: Update on the Draft Recovery Plan and Convening of the Annual General Meeting of Shareholders Poxel's recovery plan is currently being finalized: - Main objectives: prolong business development and partnership efforts for Imeglimine, PXL770, and PXL065; ensure the Company’s long-term viability through new financing; and resolve the Company’s existin...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders (the “Company”), today provides an update on its draft recovery plan and confirms the convening of its Annual General Meeting of Shareholders. Nicolas Trouche, CEO of Poxel, s...

GOLDEN, Colo.--(BUSINESS WIRE)--ASTMH presentations to focus on why an increasing number of drug developers are exploring benefits that Tropis ID brings to their product development...